Verily is an Alphabet company dedicated to bringing the promise of precision health to everyone, every day. Founded in 2015, the company focuses on applying evidence from various sources to transform healthcare delivery and empower individuals to manage their health more effectively. Verily's efforts aim to shift the healthcare paradigm from generalized medicine to personalized, comprehensive care. They operate in Analytics, Enterprise Software, Health Care, and Information Technology industries, with their headquarters located in the United States. In their latest funding round, Verily secured a $1.00B investment from Swiss Re Corporate Solutions on 28 September 2022. The company is committed to expanding its reach and impact, as evidenced by ongoing global hiring initiatives accessible through verily.com/careers. Verily's initiative to drive precision health aligns with current trends in personalized wellness and digital healthcare solutions, positioning the company for continued growth and potential investor interest. For more information, interested parties can visit verily.com.